Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/1/1991
1.
Phase II Trial of Deoxyspergualin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 07/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
any age
NCI
MSKCC-90152
NCI-T90-0225C, T90-0225
Last Modified:
7/1/1991
2.
Phase II Study of DSG Followed by a Salvage Regimen of CDDP/VP-16 in Patients with Extensive Small Cell Lung Cancer (Summary Last Modified 07/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
MDA-DM-90101
NCI-T90-0226C, T90-0226
Last Modified:
7/1/1991
3.
Phase II Study of DSG in Patients with Refractory Metastatic Breast Cancer (Summary Last Modified 07/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
16 and over
NCI
MDA-DM-90108
NCI-T90-0253C, T90-0253
Last Modified:
8/1/1991
4.
Phase II Study of Deoxyspergualin in Patients with Recurrent Intermediate- and High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 08/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
16 and over
NCI
MSKCC-91053
NCI-T91-0046C, T91-0046
Last Modified:
8/1/1989
5.
Phase I Chemotherapy with Deoxyspergualin in Patients with Advanced Cancer (Summary Last Modified 08/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
MSKCC-8640
NCI-T86-0052W, T86-0052
Last Modified:
7/1/1989
6.
Phase I Chemotherapy with Continuous Infusion Deoxyspergualin in Patients with Solid Tumors (Summary Last Modified 07/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
UTHSC-8565011093
NCI-T85-0276W, T85-0276
Last Modified:
9/1/1992
7.
Phase I Study of DSG Combined with MOAB L6 in Patients with Disseminated Carcinomas (Summary Last Modified 09/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
over 16
NCI
MDA-DM-91009
NCI-T91-0073D, T91-0073
Last Modified:
10/10/2007
8.
Phase I Pilot Study of Intravenous 131I-CC49 Monoclonal Antibody with Deoxyspergualin Immunomodulation in Patients with Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
MSKCC-93029
NCI-B92-0002, B92-0002
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute